Log-in / Create Account  
 
DIA 2013 49th Annual Meeting
Click here to go to the previous page
Regulatory, Clinical, and Quality Challenges in Contracting and Due Diligence: The Forgotten Keys to Biopharma Transactions
Track : Track 02: Project/Portfolio Management and Strategic Planning
Program Code: 243
Date: Tuesday, June 25, 2013
Time: 1:45 PM to 3:15 PM  EST
Location: 104C
CHAIR :
 Michael A. Swit, Esq, JD (SCHNON), Special Counsel, Duane Morris, LLP, United States
SPEAKER (S):
Ann Begley, BSN,JD (SPKNON), Partner, Morgan, Lewis & Bockius, LLP, United States
Gregory Dombal, Managing Partner, Halloran Consulting Group Inc.
John C. (Jack) Garvey, (SPKNON), Principal, Compliance Architects LLC, United States
Description
This session will provide drug professionals with a deeper understanding of the key regulatory, clinical or quality issues that must be reviewed in buying a biopharmaceutical product or company and how to address those concerns in the due diligence phase

Session Recording
(Code: 243)
DIA 2013 Attendee:
Attendees Login
  
This session is a part of:
DIA 2013 Live Learning Center
CON3 Comp Access: Tuesday Online Access Package - June 25, 2013
Handout Online
(Code: 243)
DIA 2013 Attendee:
Attendees Login
  
This session is a part of:
DIA 2013 Live Learning Center
CON3 Comp Access: Tuesday Online Access Package - June 25, 2013
Regulatory, Clinical, and Quality Challenges in Contracting and Due Diligence: The Forgotten Keys to Biopharma Transactions